Bayer, GIZ, MAVIM collaborate to empower rural women in Maharashtra

Published On 2021-03-12 03:30 GMT   |   Update On 2021-03-12 03:30 GMT

Mumbai: German drug and agrochemicals major Bayer on Tuesday said it has partnered with Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH and Mahila Arthik Vikas Mahamandal (MAVIM) to rebuild rural livelihoods and improve women''s health awareness in under-developed areas of Maharashtra.

Bayer, GIZ and MAVIM will support rural women smallholders in Maharashtra focusing on the districts of Vidarbha, Marathwada and Amaravati under a year-long 1 million euro (Rs 8.7 crore) COVID-response programme, Bayer said in a statement.

They are working together in a development partnership of the develoPPP.de programme, that the GIZ implements on behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ).

GIZ is a global service provider for sustainable development and education.

"This project holds special significance for us as we are contributing towards better nutrition and health for rural women, with interventions from both our Crop Science and Pharmaceuticals businesses. Bayer will support women smallholders to improve their livelihoods through agriculture and create awareness on women''s health topics," said D Narain, Senior Bayer Representative, South Asia.

Read also: Bayer gets USFDA Priority Review for finerenone for type 2 diabetes, CKD

As of date, Bayer has engaged with 30-locally registered Women Farmer Federations in 9 districts of Maharashtra covering 30 blocks.

Each of these federations have over 2,000 members and over 2,500 farmers across 13 blocks have received agri-inputs and advisory. The federations plan to procure agri-inputs for over 500 to 1,000 farmers for summer vegetables with an aim to reach 6,000 farmers throughout the Kharif season in 2021.


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News